Risk and determinants of tuberculosis recurrence: a 12-year population-based cohort study
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Tuberculosis recurrence remains a challenge to elimination efforts, particularly in high-burden settings. A better understanding of incidence, timing, and risk factors is needed to inform policies and programs for post-treatment care.
Methods
We conducted a retrospective cohort study of tuberculosis survivors successfully treated for a first tuberculosis episode between 2013 and 2024 in São Paulo state, Brazil. Data were obtained from the state tuberculosis surveillance system (TBweb), and deaths were identified through linkage with the national mortality database. We applied competing risks survival analysis to estimate incidence and assess risk factors for recurrence. Covariates included demographic, clinical, behavioral, and social vulnerability indicators, all measured at treatment initiation for the first tuberculosis episode. Risk factor models were stratified by age (<15 vs. ≥15 years).
Findings
Among 154,579 individuals who completed treatment for a first episode of tuberculosis, we identified 9,464 first recurrences over a median follow-up of 5.4 years (IQR 2.5–8.2). The overall recurrence incidence was 1,127.2 per 100,000 person-years. Rates were highest between 3–12 months after treatment completion, yet recurrence incidence remained over 1,000 per 100,000 person-years in the 2–5 years after treatment completion. In adults, hospitalization (subdistribution hazard ratio [SHR] 2.53, 95%CI 2.36–2.71), and incarceration during the initial episode (2.30, 2.13–2.48), together with pulmonary tuberculosis as initial diagnosis (2.10, 1.87–2.35) were the strongest independent risk factors for recurrence. In children, HIV (6.38, 2.64–15.40) was the strongest predictor.
Interpretation
The high and persistent risk of tuberculosis recurrence reinforces the importance of post-treatment care with risk-based follow-up strategies.
